SCHEMBL2760465

SCHEMBL2760465

C=CC1CN2CCC1C[C@@H]2Cc1ccnc2ccc(OC)cc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.65
CYP2D6 P10635 7/20 0.65
ALDH1A1 P00352 5/20 0.65
ABCB1 P08183 4/20 0.65
SLC22A1 O15245 3/20 0.65
ABCB11 O95342 3/20 0.65
ADRA2A P08913 3/20 0.65
SLC6A4 P31645 3/20 0.65
OPRM1 P35372 3/20 0.65
SCN1A P35498 3/20 0.65
KCNH2 Q12809 3/20 0.65
SCN2A Q99250 3/20 0.65
SCN3A Q9NY46 3/20 0.65
CYP3A4 P08684 3/20 0.65
HSD17B10 Q99714 3/20 0.65
SLC22A2 O15244 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
THRB P10828 1/20 0.65
ABCC4 O15439 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15278795 1.00 KDM4E (0.65) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL30225036 1.00 KDM4E (0.65) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL8328390 1.00 KDM4E (0.65) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL13283984 1.00 KDM4E (0.65) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL30097942 1.00 KDM4E (0.65) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL23795692 0.86 CYP2D6 (0.49) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL13763222 0.85 CYP2D6 (0.51) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL21228998 0.85 KDM4E (0.51) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL14535338 0.85 CYP2D6 (0.64) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1
SCHEMBL2760468 0.85 CYP2D6 (0.64) KDM4ECYP2D6ALDH1A1ABCB1SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120004424-A1 MICHAEL REACTION WITH RECOVERY OF THE CATALYST NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120004424-A1 MICHAEL REACTION WITH RECOVERY OF THE CATALYST CYP2E1, CYP11B2, CYP11B1 KDM4E 3536/4885CYP2D6 40/4885ALDH1A1 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.